2003
$125M
from 20 investors over 20 rounds
Portola Pharmaceuticals raised $125M on March 4, 2019
Investors: Athyrium Capital Management, LP and HealthCare Royalty Partners
Portola Pharmaceuticals raised $89M on November 21, 2011
Investors: - and Temasek
Portola Pharmaceuticals raised $45M on October 1, 2011
Investors: Biogen Idec
Portola Pharmaceuticals raised $60M on July 1, 2008
Investors: Frazier Healthcare Partners, MPM Capital, Prospect Venture Partners, LP, T. Rowe Price and The D. E. Shaw Group
Portola Pharmaceuticals raised $70M on May 7, 2007
Investors: T. Rowe Price, Brookside Capital Inc, Frazier Healthcare Partners and MPM Capital
Portola Pharmaceuticals raised $46M on November 8, 2005
Investors: Advanced Technology Ventures, Abingworth, Alta Partners, Frazier Healthcare Partners, MPM Capital and Prospect Venture Partners, LP